Yale Cancer Center Diversity Enhancement Program in Oncology welcomes first students
The Diversity Enhancement Program in Oncology program offers an eight-week rotation for two underrepresented in medicine (URiM) students or residents, and is designed to provide exposure to hematology/medical oncology as a career, provide faculty-mentored clinical experience in oncology as well as with a corresponding clinical or translational research project. Students also receive co-mentorship from current Medical Oncology-Hematology T32 fellows.
Insights & Outcomes: Biofilms, cravings, and cells that spill their guts
Neutrophil extracellular traps (NETs) are important for health but if neutrophils go overboard and spill their guts too often, they can actually contribute to inflammatory diseases like cystic fibrosis, cancer, COVID-19, and more. Being able to calm neutrophils and rein in NETs could help treat these diseases. In a study recently published in the journal ImmunoHorizons, James E. Hansen, MD, MS, and his colleagues found that a certain lupus antibody can do just that.Source: YaleNews
Advances For Patients with Sickle Cell Disease
In just under a decade, the Sickle Cell Program at Smilow Cancer Hospital has transformed care for patients and reduced emergency room visits by 60% and hospitalizations by 53%. Dr. Cecelia Calhoun is committed to continued improvements for patients.
Understanding Poor Vaccine Responses in Individuals With Weakened Immune Systems
Yale researchers have received a $12 million award from the NIH as part of the Human Immune Project Consortium to study vaccine responses in vulnerable groups, including patients with multiple sclerosis (MS) undergoing B cell depletion therapy, older adults including particularly vulnerable older residents of long-term care facilities, and certain individuals with sickle cell disease.
American Society of Hematology Selects Yale Cancer Center for Innovative Fellowship Training Program
Yale Cancer Center is pleased to announce that it has been selected by the American Society of Hematology (ASH) for the ASH Hematology-Focused Fellowship Training Program (HFFTP), an initiative to address the critical need to expand the hematology workforce.
Elevated Biomarkers Offer Early Indicator of Severe COVID-19, Study Says
When patients with COVID-19 arrive in emergency rooms, there are relatively few ways for doctors to predict which ones are more likely to become critically ill and require intensive care and which ones are more likely to enjoy a quick recovery. Recent Yale research could help them identify important early clues that foretell severe cases of COVID-19.
Yale Hematology Appoints two Fellows to Faculty Positions
Yale Cancer Center is pleased to welcome Anna Kress, MD, and George Goshua, MD, MSc, to the section of Hematology. Drs. Kress and Goshua will both complete the Yale Medical Oncology-Hematology Fellowship Program and begin their new appointments in July.